Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07276724 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 110 → 123 locations
  2. Trial sites expanded: 96 → 110 locations Eligibility criteria expanded, about 38 words · Secondary endpoints: details revised at 13 of 14 entries · Study description expanded, about 4 words Show 3 more changesShow less
    • Eligibility criteria expanded, about 38 words
    • Secondary endpoints: details revised at 13 of 14 entries
    • Study description expanded, about 4 words
  3. Trial sites expanded: 78 → 96 locationsv13
  4. Re-verified, no change to tracked fieldsv12
  5. Trial sites expanded: 67 → 78 locationsv11
  6. Trial sites expanded: 53 → 67 locationsv10
  7. Trial sites expanded: 35 → 53 locationsv9
  8. Trial sites expanded: 29 → 35 locationsv8
  9. Study sites: 27 to 29v7
  10. Study sites: 25 to 27v6
  11. Trial sites expanded: 21 → 25 locationsv5
  12. Trial sites expanded: 13 → 21 locationsv4
  13. Trial status: Not Yet Recruiting to Recruiting Study sites: 1 to 13 · Start date changed from estimate of Dec 2025 to Dec 3, 2025v3 Show 2 more changesShow less
    • Study sites: 1 to 13
    • Start date changed from estimate of Dec 2025 to Dec 3, 2025
  14. Re-verified, no change to tracked fieldsv2
  15. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. Additional information is available at www.SOLAIRIA.com.
Trial Details
NCT Number NCT07276724
Lead Sponsor Generate Biomedicines
Conditions Severe Asthma
Enrollment 786 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov